Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Exam (elaborations)

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2025 GRADED A+

Rating
-
Sold
-
Pages
15
Grade
A+
Uploaded on
08-04-2025
Written in
2024/2025

NR 546 Week 5 Antidepressant and Mood Stabilizer Medication Table latest update 2025 GRADED A+

Institution
Course

Content preview

Week 5 antidepressant
table

, Antidepressant Medications

Name Indication, starting dose, Half-life Notes/Notable side effects/Precautions
target symptoms, and (T1/2)
affected neurotransmitters CYP450
enzyme
SSRIs
Citalopram Selective serotonin reuptake Parent drug Notable side effects: sexual dysfunction, decreased appetite, N/V/D,
(Celexa) inhibitor 23-45 hour constipation, dry mouth, dose-dependent insomnia, agitation, tremors,
half-life. headache, dizziness, sweating, bruising and rare bleeding.
Commonly prescribed for
depression, PMDD, OCD, panic Weak Precautions: rare seizures, rare mania, rare activation of suicidal
disorder, GAD, PTSD, social inhibitor of ideation, sedation. Caution with patients with seizure disorders, bipolar
anxiety disorder CYP450 2D6. disorder, monitor for SI in children and adolescents

Starting dose: 20mg/day Metabolized Notes: mild antihistamine properties may contribute to sedation and
by CYP450 fatigue in some. Risks versus benefits in pregnancy and breast feeding.
Blocks serotonin and serotonin 3A4 and
reuptake pump, desensitizes 2C19
serotonin receptors,
presumably increases
serotonergic
neurotransmission
Escitalopram Selective serotonin reuptake Mean Notable side effects: sexual dysfunction, decreased appetite, N/V/D,
(Lexapro) inhibitor terminal half constipation, dry mouth, dose-dependent insomnia, agitation, tremors,
life 27-32 headache, dizziness, sweating, bruising and rare bleeding.
Commonly prescribed for hours.
MDD, GAD, panic disorder, Precautions: rare seizures, rare mania, rare activation of suicidal
OCD, PTSD, social anxiety Substrate for ideation, sedation. Caution with patients with seizure disorders, bipolar
disorder, and PMDD CYP450 2C19 disorder, monitor for SI in children and adolescents
and 3A4
Starting dose: 10mg/day Notes: may be among the best tolerated antidepressants. Commonly
No used as an augmenting agent as it has least interactions with CYP450.
Blocks serotonin and serotonin significant
reuptake pump, desensitizes actions of
serotonin receptors,

Written for

Course

Document information

Uploaded on
April 8, 2025
Number of pages
15
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

$11.58
Get access to the full document:

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Get to know the seller
Seller avatar
reagankaiya

Get to know the seller

Seller avatar
reagankaiya Walden University
Follow You need to be logged in order to follow users or courses
Sold
9
Member since
1 year
Number of followers
0
Documents
385
Last sold
5 months ago

0.0

0 reviews

5
0
4
0
3
0
2
0
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions